Dr. Ranjith Ramasamy discusses research evaluating COVID-19 and erectile dysfunction

The oral TRT study plans to enroll 20 male patients aged 18 to 49 years who meet the American Urological Association’s criteria for hypogonadism and who have not previously used TRT.

“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.

Novel research to evaluate noninvasive treatments in erectile dysfunction and chronic pelvic pain

“I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.

“Sexual wellness is critical to overall health and happiness. That’s why you see more men and women turning to specialty health clinics for solutions to problems they consider more aesthetic versus medical,” said Mitchell Hollander, MD.

At 3 months following treatment, 50% of men who received CCH injections reported being “very satisfied” overall, compared with 21% of patients in the surgery group.